Loading...

Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis

New treatments, such as sipuleucel-T and androgen receptor- (AR-) directed therapies (enzalutamide (Enz) and abiraterone acetate (AA)), have emerged and been approved for the management of castration-resistant prostate cancer (CRPC). There are still debates over their efficacy and clinical benefits....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Immunol Res
Main Authors: Yi, Renliang, Chen, Baoxin, Duan, Peng, Zheng, Chanjiao, Shen, Huanyu, Liu, Qun, Yuan, Chen, Ou, Weilin, Zhou, Zhiheng
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi Publishing Corporation 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5183769/
https://ncbi.nlm.nih.gov/pubmed/28058266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4543861
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!